SOLTF (Nxera Pharma Co) 3-Year Revenue Growth Rate : 14.40% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co 3-Year Revenue Growth Rate?

Nxera Pharma Co's Revenue per Share for the three months ended in Dec. 2024 was $0.50.

During the past 12 months, Nxera Pharma Co's average Revenue per Share Growth Rate was 107.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 14.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 17.20% per year. During the past 10 years, the average Revenue per Share Growth Rate was 13.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Nxera Pharma Co was 87.40% per year. The lowest was -36.20% per year. And the median was 14.40% per year.

Competitive Comparison of Nxera Pharma Co's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Nxera Pharma Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's 3-Year Revenue Growth Rate falls into.

Save Embed

;

Save Embed

;

Nxera Pharma Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Nxera Pharma Co (OTCPK:SOLTF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Nxera Pharma Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

4565:Japan

Address

Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website

https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).